tirzepatide ophthalmic side effects Eye Complications from Semaglutide and Can Ozempic-like Drugs Cause Blindness?

Semaglutide, which was approved in June 2021, and tirzepatide, which was approved in November 2023, have demonstrated a strikingly significant weight reduction induced by a therapeutic agent, with one third of patients achieving efficacy comparable to metabolic and bariatric surgeries

These are the least calorie-dense and most nutrient-dense options

Factors such as side effect profiles, coexisting medical conditions, access, and cost must be considered

Gs June 4, 2026 Embarking on a journey toward better health is an exciting and transformative step

The study included 17,604 adults over the age of 45 from across 41 countries, each with a BMI of more than 27 and established cardiovascular disease, with no history of diabetes

However, most people notice a shift in several key areas: Mental Clarity: Reduced brain fog and better focus during the workday